Cargando…
ZEB1 induces EPB41L5 in the cancer mesenchymal program that drives ARF6-based invasion, metastasis and drug resistance
Onset of the cancer mesenchymal program is closely associated with cancer malignancy and drug resistance. Among the different epithelial–mesenchymal transition (EMT)-associated transcriptional factors, ZEB1 has a key role in inducing the mesenchymal phenotypes and stem cell-like properties of differ...
Autores principales: | Hashimoto, A, Hashimoto, S, Sugino, H, Yoshikawa, A, Onodera, Y, Handa, H, Oikawa, T, Sabe, H |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5047961/ https://www.ncbi.nlm.nih.gov/pubmed/27617643 http://dx.doi.org/10.1038/oncsis.2016.60 |
Ejemplares similares
-
Arf6 and its ZEB1-EPB41L5 mesenchymal axis are required for both mesenchymal- and amoeboid-type invasion of cancer cells
por: Handa, Haruka, et al.
Publicado: (2017) -
High expression of EPB41L5, an integral component of the Arf6-driven mesenchymal program, correlates with poor prognosis of squamous cell carcinoma of the tongue
por: Otsuka, Yutaro, et al.
Publicado: (2016) -
Lysophosphatidic acid activates Arf6 to promote the mesenchymal malignancy of renal cancer
por: Hashimoto, Shigeru, et al.
Publicado: (2016) -
P53- and mevalonate pathway–driven malignancies require Arf6 for metastasis and drug resistance
por: Hashimoto, Ari, et al.
Publicado: (2016) -
EPB41L5 functions to post-transcriptionally regulate cadherin and integrin during epithelial–mesenchymal transition
por: Hirano, Mariko, et al.
Publicado: (2008)